Prakash Manoharan
About
In The Last Decade
Prakash Manoharan
39 papers receiving 583 citations
Peers
Comparison fields: 5 of 52
- Oncology 344
- Surgery 298
- Pulmonary and Respiratory Medicine 238
- Epidemiology 139
- Radiology, Nuclear Medicine and Imaging 64
Countries citing papers authored by Prakash Manoharan
This map shows the geographic impact of Prakash Manoharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prakash Manoharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prakash Manoharan more than expected).
Fields of papers citing papers by Prakash Manoharan
This network shows the impact of papers produced by Prakash Manoharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prakash Manoharan. The network helps show where Prakash Manoharan may publish in the future.
Co-authorship network of co-authors of Prakash Manoharan
This figure shows the co-authorship network connecting the top 25 collaborators of Prakash Manoharan. A scholar is included among the top collaborators of Prakash Manoharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prakash Manoharan. Prakash Manoharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 33 | |
| 4 | 12 | |
| 5 | 4 | |
| 6 | 20 | |
| 7 | 1 | |
| 8 | 30 | |
| 9 | 113 | |
| 10 | 76 | |
| 11 | Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence. | 1 |
| 12 | 10 | |
| 13 | 4 | |
| 14 | 9 | |
| 15 | 7 | |
| 16 | 19 | |
| 17 | 35 | |
| 18 | 4 | |
| 19 | 0 | |
| 20 | 6 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.